ADVANCED SOLID TUMORS CANCER
Clinical trials for ADVANCED SOLID TUMORS CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOLID TUMORS CANCER trials appear
Sign up with your email to follow new studies for ADVANCED SOLID TUMORS CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug enters first human trials for Tough-to-Treat tumors
Disease control Recruiting nowThis is the first study in people to test a new drug called PQ203 for advanced solid tumors, including a hard-to-treat type of breast cancer. The main goals are to check if the drug is safe and to find the best dose for future studies. About 80 adults who have run out of standard…
Matched conditions: ADVANCED SOLID TUMORS CANCER
Phase: PHASE1 • Sponsor: ProteinQure Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
New pill tested to fight advanced cancers
Disease control Recruiting nowThis early-stage study is testing a new oral drug called NDI-219216 in patients with advanced solid tumors that have not responded to standard treatments. The main goals are to find a safe dose, understand how the drug works in the body, and see if it can shrink tumors. Participa…
Matched conditions: ADVANCED SOLID TUMORS CANCER
Phase: PHASE1, PHASE2 • Sponsor: Nimbus Wadjet, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New drug combo targets 'Undruggable' cancer mutation in advanced patients
Disease control Recruiting nowThis study is testing whether combining the experimental drug GFH375 with either cetuximab or chemotherapy can help control advanced solid tumors that have a specific KRAS G12D mutation. The trial will enroll 126 adults whose cancers have progressed despite standard treatments. R…
Matched conditions: ADVANCED SOLID TUMORS CANCER
Phase: PHASE1, PHASE2 • Sponsor: Genfleet Therapeutics (Shanghai) Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
New cancer drug begins first human safety tests
Disease control Recruiting nowThis early-stage study is testing a new drug called ORB-021 in people with advanced solid tumors that haven't responded to standard treatments. The main goal is to check if the drug is safe and to find the best dose for future studies. Researchers will give the drug through an IV…
Matched conditions: ADVANCED SOLID TUMORS CANCER
Phase: PHASE1 • Sponsor: Orionis Biosciences Inc • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
Lab tests aim to predict which cancer patients will benefit from immunotherapy
Knowledge-focused Recruiting nowThis study collects tumor tissue samples from cancer patients to research whether laboratory tests can predict which patients will respond to immunotherapy drugs. Researchers will analyze how live tumor samples react to immunotherapy treatments in the lab, then compare those resu…
Matched conditions: ADVANCED SOLID TUMORS CANCER
Sponsor: Elephas • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC